
|Articles|June 20, 2017
- June 2017 Women's Health
- Volume 83
- Issue 6
Can You Read These Rxs? (June 2017)
Can you figure out what these prescriptions say?
Advertisement
Send in your eye-straining, baffling prescriptions—now via e-mail and fax as well as regular mail! Submissions must include a clean photocopy or scanned image of the Rx; your institution’s name and location; your name and title; the correct name of the drug(s), strength, and dosing requirements; and your phone number. You can e-mail scanned Rxs to rmarotta@pharmacytimes.com; fax them to 609-257-0701; or mail them to Can You Read These Rxs?, Pharmacy Times, 2 Clarke Drive, Suite 100, Cranbury, NJ 08512.
Articles in this issue
over 9 years ago
Case Studies (June 2017)over 9 years ago
Pet Peeves (June 2017)over 9 years ago
Generic Product News (June 2017)over 9 years ago
Naloxone Nasal Spray More Generics on the Horizon?over 9 years ago
Medication Therapy Management and Health Care Reformover 9 years ago
Mental Illness Linked to Heightened Cardiovascular Disease Riskover 9 years ago
Poor Diet Linked to Premenopausal Breast Cancer RiskAdvertisement
Related to this article

A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.

Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.

The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.

Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.

Two recent graduates share strategies for standing out in the competitive fellowship application process.

Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
2
Flu Vaccination Linked to Fewer Severe Outcomes in Older Adults, Fewer ED Visits in Children
3
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
4
Combined Cardiometabolic Biomarker Burden Tracks CKM Progression
5


